Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

North Carolina takes historic step for health with the implementation of smoke-free law

North Carolina on January 2 will take an historic step for health when it becomes the first major tobacco-growing state to implement a statewide smoke-free law that includes all restaurants and bars. This new law will protect the right of North Carolinians to breathe clean air.

4 Jan 2010

ESS improves quality of life in CRS patients

Upwards of 76 percent of patients with chronic rhinosinusitis (CRS) experienced significant quality of life (QOL) improvements after undergoing endoscopic sinus surgery (ESS), according to new research in the January 2010 issue of Otolaryngology - Head and Neck Surgery.

3 Jan 2010

Sharing Miracles: A TV program that features inspirational stories of real patients

Major League Baseball slugger Aaron Boone will be featured on January's episode of Sharing Miracles - a 30-minute public affairs television program that tells the compelling and inspirational stories of real patients. Sharing Miracles airs every week on more than 300 television stations nationwide.

31 Dec 2009

Presence of Streptococcus pneumoniae could predict risk of severe disease in H1N1 pandemic influenza

The presence of the Streptococcus pneumoniae in samples that can be easily obtained in clinics and emergency rooms may predict risk of severe disease in H1N1 pandemic influenza.

31 Dec 2009

CVS Caremark to provide H1N1 flu vaccinations at selected locations

CVS Caremark announced today that it will provide H1N1 flu vaccinations at select CVS/pharmacy locations in the States of Alabama, Illinois, Kansas, Missouri, Pennsylvania and New York as well at MinuteClinic locations in Massachusetts and Connecticut beginning Thursday, December 31.

30 Dec 2009

Luna Innovations acquires intellectual property assets of Tego Biosciences

Luna Innovations Incorporated has acquired certain intellectual property assets of Tego Biosciences, its main competitor in developing medicines based on carbon nanomaterials.

29 Dec 2009

Emerald BioStructures engineers new allosteric small molecule modulators of the PDE4 enzyme

Emerald BioStructures (formerly deCODE biostructures) announced today a publication in the December 27, 2009 advance online issue of Nature Biotechnology, detailing the application of structure-based drug design (SBDD) to engineer new allosteric small molecule modulators of the enzyme phosphodiesterase-4 (PDE4), with reduced side effects. According to the paper, the researchers established the structural basis of PDE4 regulation through crystal structures of the PDE4 regulatory domain in contact with small molecules.

29 Dec 2009

Selected store locations in Massachusetts, Virginia and California to receive H1N1 flu vaccinations

CVS/pharmacy announced today that it will provide H1N1 flu vaccinations at select store locations in Massachusetts, Virginia and Orange County, California beginning Tuesday, December 29.

29 Dec 2009

Publication validates company's structure-based approach for addressing undruggable targets

28 Dec 2009

New series of 30-second PSAs on getting vaccinated against H1N1 flu

The U.S. Department of Health and Human Services (HHS), in conjunction with the Ad Council and the Jim Henson Company, has released a new series of 30-second public service announcements (PSAs) about the importance of getting the 2009 H1N1 vaccine. Targeted to parents and children, the PSA campaign features 15 governors, a state first lady, a state chief medical officer and the main character from the PBS’ series “Sid the Science Kid” and reminds the public that getting vaccinated is the best way to stay healthy during this flu season.

24 Dec 2009

CVS/pharmacy and MinuteClinic expand H1N1 vaccine outreach effort

CVS/pharmacy, the nation's leading retail pharmacy, and MinuteClinic, the largest retail health care provider in the U.S., announced today an expanded H1N1 vaccine outreach effort.

24 Dec 2009

Ligand Pharmaceuticals acquires Neurogen

Ligand Pharmaceuticals Incorporated announced today that it has completed the acquisition of Neurogen Corporation, following approval of the transaction by Neurogen stockholders earlier today. As a result, Ligand gains a fully funded partnership with Merck & Co., additional pipeline assets, drug discovery resources and additional cash balances.

23 Dec 2009

Majority of Australians think H1N1 vaccination is not necessary

Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.

23 Dec 2009

Thyroid cancer on the rise

As seen on "NBC Nightly News" Monday, December 21, the thyroid cancer rate is rising rapidly, especially among women. The American Thyroid Association's members are working to educate more people about thyroid cancer as well as treat and cure it.

23 Dec 2009

Gene's role in immune system may suggest new treatments for childhood asthma

Pediatric researchers have identified a novel gene involved in childhood asthma, in one of the largest gene studies to date of the common respiratory disease. Because the gene, called DENND1B, affects cells and signaling molecules thought to be instrumental in the immune system overreaction that occurs in asthma, the discovery may have singled out an important target for new treatments.

23 Dec 2009

Rigel Pharmaceuticals announces milestone payment from Daiichi Sankyo

Rigel Pharmaceuticals, Inc. today announced that it has received a milestone payment from Daiichi Sankyo Co., Ltd. as part of their collaboration to research and develop cancer treatments aimed at selectively inhibiting ligases, which are intrinsic to cancer cell growth and proliferation. The compound, as yet unnamed, targets cell division.

23 Dec 2009

Researchers mix active drug and placebo to maximize drug benefits for efficient treatment

Researchers used the placebo effect to successfully treat psoriasis patients with one quarter to one half of their usual dose of a widely used steroid medication, according to an early study published online today in the journal Psychosomatic Medicine.

23 Dec 2009

Asthma News and Research

Further Reading

North Carolina takes historic step for health with the implementation of smoke-free law

ESS improves quality of life in CRS patients

Sharing Miracles: A TV program that features inspirational stories of real patients

Presence of Streptococcus pneumoniae could predict risk of severe disease in H1N1 pandemic influenza

CVS Caremark to provide H1N1 flu vaccinations at selected locations

Luna Innovations acquires intellectual property assets of Tego Biosciences

Emerald BioStructures engineers new allosteric small molecule modulators of the PDE4 enzyme

Selected store locations in Massachusetts, Virginia and California to receive H1N1 flu vaccinations

Publication validates company's structure-based approach for addressing undruggable targets

New series of 30-second PSAs on getting vaccinated against H1N1 flu

CVS/pharmacy and MinuteClinic expand H1N1 vaccine outreach effort

Ligand Pharmaceuticals acquires Neurogen

Majority of Australians think H1N1 vaccination is not necessary

Thyroid cancer on the rise

Gene's role in immune system may suggest new treatments for childhood asthma

Rigel Pharmaceuticals announces milestone payment from Daiichi Sankyo

Researchers mix active drug and placebo to maximize drug benefits for efficient treatment

CVS/pharmacy to provide H1N1 flu vaccinations at select store locations in Rhode Island

Prolonged exposure to higher levels of pollutants can lead to hospitalization for pneumonia

Viron Therapeutics' three drug candidates granted U.S. patents

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News